NCT04350320View on ClinicalTrials.gov

Trial to Study the Benefit of Colchicine in Patients With COVID-19

PHASE3CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

April 30, 2020

Primary Completion Date

October 20, 2020

Study Completion Date

December 30, 2020

Conditions
COVID19
Interventions
DRUG

Colchicine Tablets

standard therapy for COVID-19 according to the stablished hospital protocols.

DRUG

Standard therapy for COVID-19 according to the stablished hospital protocols.

standard therapy for COVID-19 according to the stablished hospital protocols.

Trial Locations (1)

30120

Virgen de la Arrixaca University Clinical Hospital, Murcia

All Listed Sponsors
lead

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

OTHER

NCT04350320 - Trial to Study the Benefit of Colchicine in Patients With COVID-19 | Biotech Hunter | Biotech Hunter